Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics.
about
Opportunities and challenges for TCR mimic antibodies in cancer therapyAcute myeloid leukemia targets for bispecific antibodies.Therapeutic Antibodies against Intracellular Tumor AntigensComparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains.Engineering chimeric antigen receptor-T cells for cancer treatment.TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies.
P2860
Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics.
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics.
@ast
Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics.
@en
type
label
Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics.
@ast
Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics.
@en
prefLabel
Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics.
@ast
Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics.
@en
P2093
P2860
P1476
Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics.
@en
P2093
David A Scheinberg
Jingyi Xiang
Neal Cheng
Niloufar Ataie
P2860
P304
P356
10.1016/J.JMB.2015.12.002
P407
P577
2015-12-11T00:00:00Z